Cytosorbents Corp — Director's Dealing 2016

Jun 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2016-06-07

Reporting Person: BATOR MICHAEL G. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-07	Common Stock	P	3000	$4.88	Acquired	3000	Direct
2016-06-07	Common Stock	A	60000	—	Acquired	63000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-07	Stock Option (right to buy)	$4.69	A	12000	Acquired	2026-06-07	Common Stock (12000)	Direct

Footnotes

F1: The price in column 4 is a weighted average price. The prices actually paid in this transaction range from $4.86 to $4.90.

F2: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.

F3: These shares represent restricted stock units and will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan.

F4: Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, which vest in four equal parts at the end of each calendar quarter beginning June 30, 2016.